Latest News

  • Galatea Bio, Fabric Genomics Combine Pathogenic Variant Analysis with Polygenic Risk Score

    Diagnostics World | Galatea Bio and Fabric Genomics announced a strategic collaboration this week to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to assess genetic susceptibility to common diseases.

    Jun 26, 2025

  • Follow the Money: Neuroplastogens Novel Therapies, Genetic Medicines, More

    Diagnostics World | Elkedonia SAS plans to develop the drug-like small molecule inhibitors of Elk1, a novel intracellular target that plays a pivotal role in reward brain circuits and neuroplasticity; SpliceBio will advance the clinical development of their lead gene therapy candidate, SB-007, for Stargardt disease; and more.

    Jun 25, 2025

  • Veeva, Sarah Cannon Research Institute Collaboration, City of Hope Receives Grant, More

    Diagnostics World | Veeva and Sarah Cannon Research Institute has entered a strategic collaboration; City of Hope was awarded an up to $23.7 million contract from the Advanced Research Projects Agency for Health within the US Department of Health and Human Services; and more.

    Jun 24, 2025

  • Nanoneedle Technology Could Transform Medical Diagnostics

    Diagnostics World | Researchers at King's College London have developed a diagnostic tool that could enable doctors to sample tissue during critical medical procedures. The nanoneedle patch technology enables physicians to extract molecular information from living tissue without causing damage or killing cells—a capability that could prove especially valuable in delicate surgical situations.

    Jun 20, 2025

  • Real-time Molecule Monitoring Could Put an End to ‘Reactive Medicine’

    Diagnostics World | Modern jet engines can generate a terabyte or more of data per hour that gets transmitted back to the engine manufacturer to ensure aircraft safety and prevent disasters from happening. Yet the human body, arguably the most important machinery of them all, gets checked only once a year or whenever something has already gone wrong.

    Jun 17, 2025

  • Myeloma Diagnostics: Ultra-Sensitive Detection and Population-Scale Screening Transform Disease Management

    Diagnostics World | The International Myeloma Foundation's Black Swan Research Initiative is changing how multiple myeloma is detected, monitored, and managed. From single-cell detection technologies to population-scale screening programs, these advances are setting new standards for precision oncology diagnostics.

    Jun 12, 2025

  • Pharmacogenomic Testing Shows Value in Improving Prescribing Precision

    Diagnostics World | After the human genome was sequenced in 2003, expectations were high that it would drive direct and immediate benefits for the everyday healthcare of the general population. While genomics has fundamentally altered the clinical pathways for individuals with rare diseases and cancer, it has yet to become part of routine clinical practice.

    Jun 11, 2025